International Journal of Tumor Therapy
p-ISSN: 2163-2189 e-ISSN: 2163-2197
2012; 1(2): 6-13
doi: 10.5923/j.ijtt.20120102.01
Saratchandran A. Divakaran1, 2, Cherupally Krishnan Krishnan Nai3
1Amala Cancer Research Centre, 680555, Thrissur
2Sree Kerala Varma College, Thrissur, Kerala, 680011, India
3Pushpagiri Institute of Medical Sciences & Research Centre, Thiruvalla Kerala, 689101, India
Correspondence to: Cherupally Krishnan Krishnan Nai, Pushpagiri Institute of Medical Sciences & Research Centre, Thiruvalla Kerala, 689101, India.
Email: |
Copyright © 2012 Scientific & Academic Publishing. All Rights Reserved.
Doxorubicin (DOX) is one of the most effective anticancer therapeutic but its use is limited by cardiotoxicity. The generation of reactive oxygen species (ROS) and mitochondrial dysfunction have been implicated in DOX-induced cardiotoxicity. Cardiotoxicity was induced in tumor bearing mice by a single dose of DOX (25mg/kg, i.p). Ferulic acid (FA) (100 mg/kg p.o and 200 mg/kg p.o) was administered one hour after DOX administration. The administration of FA significantly protected the myocardium from the toxic effects of DOX by reducing the levels of serum marker enzymes like CK and LDH and other serum enzymes SGOT and SGPT, which were elevated during DOX induced cardiomyopathy. The level of HDL was also significantly increased in FA administered groups compared to DOX control. FA protected the cardiac tissues, whereas it potentiated the anticancer efficacy of DOX in tumor tissues as evident from different antioxidant enzyme levels and the extent of lipid peroxidation. The histopathological observations also supported these results. FA effectively protected cellular DNA in heart tissue preferentially, without offering any protection to the DNA in tumour tissues as evidenced from the comet assay. These results suggest that ferulic acid has a protective effect against cardiotoxicity induced by DOX and it may, therefore improve the chemotherapeutic index of DOX.
Keywords: Cardiotoxicity, Doxorubicin, antioxidant, lipid peroxidation: tumor
Figure 1. Ferulic acid (FA) |
|
Figure 4. Effect of administration of Ferulic acid on doxorubicin- induced lipid peroxidation (MDA formation) in tumor tissues of mice. (*** indicate p<0.001 when compared with the DOX alone treated group) |
|
Figure 5. Histopathology. Representative sections of heart tissue of tumor bearing mice (A) untreated (B) DOX 25 mg/kg (C) DOX+FA 100 mg/kg and (D) DOX+FA 200 mg/kg |
Figure 6. Histopathology. Representative sections of tumor tissue of tumor bearing mice (A) untreated (B) DOX 25 mg/kg (C) DOX+FA 100 mg/kg and (D) DOX+FA 200 mg/kg |
Figure 7. Effect of Ferulic acid (100 mg/kg and 200 mg/kg) on DNA damage in mice cardiomyocytes induced by administration of doxorubicin (25mg/kg) assessed by comet assay. Percentage DNA in tail, tail length, tail moment and olive tail moment is presented as mean ± sd (*** indicate p < 0.001 when compared with DOX alone treated group) |
Figure 8. Effect of Ferulic acid (100 mg/kg and 200 mg/kg ) on DNA damage in tumor tissues of tumor bearing mice induced by administration of doxorubicin (25mg/kg) assessed by comet assay. Percentage DNA in tail, tail length, tail moment and olive tail moment is presented as mean ± sd (*** indicate p < 0.001 when compared with DOX alone treated group) |
[1] | P K Singal and N Iliskovic., 1998, Doxorubicin-induced cardiomyopathy., N Engl J Med., 339, 900-905. |
[2] | D D Von Hoff, M W Layard and Basa P., 1979, Risk factors for doxorubicin-induced congestive heart failure. Ann Intern Med, 91, 710-7. |
[3] | C F Myers, W P Mc Guire and R H liss., 1977, Adriamycin. The role of lipid peroxidation in cardiotoxicity and tumor response. Science., 197, 165-167. |
[4] | C C Bier and R S Jaenke., 1976, Function of myocardial mitochondria in the Adriamycin induced cardiomyopathy of rabbits. J Natl Cancer Inst., 57, 1091-4. |
[5] | A Geetha and C S Devi., 1992, Effect of doxorubicin on heart mitochondrial enzymes in rats: A protective role for alpha tocopherol. Indian J exp Biol., 30, 615-8. |
[6] | J H Doroshow., 1991, Doxorubicin-induced cardiac toxicity. N Engl J Med., 324, 843-845. |
[7] | M F Xu, P L Tang, Z M Qian and M Ashraf., 2001, Effects by doxorubicin on the myocardium are mediated by oxygen free radicals. Life Sci., 68, 889-901. |
[8] | M A Abou-El-Hassan, M J Rabelink, W J van der Vijgh, A Bast and RC Hoeben., 2003, A comparative study between catalase gene therapy and the cardioprotector monohydroxyethylrutoside (MonoHER) in protecting against doxorubicin-induced cardiotoxicity in vitro. Br J Cancer., 89, 2140-6. |
[9] | X Liu, Z Chen, CC Chua, Y Ma, GA Youngberg, R Hamdy and BHL Chua., 2002, Melatonin as an effective protector against Doxorubicin induced cardiotoxicity. Americ J Physiol Heart and Circulatory Physiol., 283, H254-H263. |
[10] | Nakagawa and Yokozawa T., 2002, Direct scavenging of nitric oxide and superoxide by green tea. Food Chem. Toxicol., 40, 1745-50. |
[11] | E Graf., 1992, Antioxidant potential of ferulic acid. Free Radical Biol Med., 13, 435-48. |
[12] | W Kuenzig, J Chau, E Norkus, H Holowaschenko, H Newmark, W Mergens and A H Conney., 1984, Caffeic and ferulic acid as blockers of nitrosamine formation. Carcinogenesis., 5, 309-313. |
[13] | M Sreenivasan, AR Sudheer and VP Menon., 2007, Ferulic acid : Therapeutic Potential Through its antioxidant property. Recent Advances In Indian Herbal Drug Research. J. Clin. Biochem Nutr., 40, 92-100. |
[14] | DK Maurya, VP Salvi and CKK Nair., 2005, Radiation protection of DNA by ferulic acid under in vitro and in vivo conditions. Mol Cell Biochem., 280, 209-17. |
[15] | JM Mc Cord and I Fridovich., 1969, Superoxide dismutase enzyme function for erythrocuprein (hemocuprein). J Bio Chem., 244, 6049-6055. |
[16] | DG Hafemann, RA Sunde and WG Hoekstra., 1974, Effect of dietary selenium on erythrocyte and liver glutathione peroxides in the rat. J Nutr., 104, 580-587. |
[17] | M S Moron, JN De Pierre and V Mannervik., 1979, Levels of glutathione glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochim Biophys Acta., 582, 67-78. |
[18] | A J Buege and S D Aust., 1978, Microsomal Lipid Peroxidation. Methods Enzymol., 52, 302-10. |
[19] | DK Chandrasekharan, VT Kagiya and CKK Nair., 2009, Radiation protection by 6- palmitoyl ascorbic acid- 2-glucoside: studies on DNA damage in vitro, ex vivo, in vivo and oxidative stress in vivo. J Radiat Res., 50, 203-12. |
[20] | H Cerda, H Delincee, H Haine and H Rupp., 1997, The DNA ‘Comet Assay’ as a Rapid Screening Technique to Control Irradiated Food. Mutat Res /Fundam Mol Mech Mugag., 375, 167-81. |
[21] | K Konca, A Lankoff, A Banasik, H Lisowka, T Kuszewski, S Gozdz, Z Koza and A Wojcik., 2003, Across Platform Public Domain PC Image Analysis Programme for the Comet Assay. Mutat Res., 534, 15-20. |
[22] | D Sandeep and CKK Nair., 2010, Protection of DNA and membrane from γ-radiation induced damage by the extract of Acorus calamus Linn.: an in vitro study. Environ Toxicol Pharmacol., 29, 302-307. |
[23] | S V Kalivendi, S Kotamraju, H Zhao, J Joseph and Kalyanaraman B., 2001, Doxorubicin-induced apoptosis is associated with increased transcription of endothelial nitric-oxide synthase. Effect of antiapoptotic antioxidants and calcium. J Of Biol Chem., 276, 47266–47276. |
[24] | S Wang, EA Konorev S, Kotamraju, J Joseph, S Kalivendi and B Kalyanaraman., 2004, Doxorubicin induces apoptosis in normal and tumor cells via distinctly different mechanisms. intermediary of H(2)O(2)- and p53-dependent pathways. J Of Biol Chem., 279, 25535–25543. |
[25] | V Lee, A K Randhawa and P K Singal., 1991, Adriamycin-induced myocardial dysfunction in vitro is mediated by free radicals. Am J Of Physiol., 261, H989–H995. |
[26] | E Saltiel and Wv McGuire., 1983, Doxorubicin (Adriamycin) cardiomyopathy (Medical Progress). West J of Med, 139, 332-341. |
[27] | M Yagmurca, E Fadillioglu, H Erdogan, M, S Ucar Sogut and M K Irmak., 2003, Erdosteine prevents doxorubicin induced cardiotoxicity in rats. Pharmacol Res., 48, 377-382. |
[28] | M N Nagi and M A Mansour., 2000, Protective effect of thymoquinone against Doxorubicin-induced cardiotoxicity in rats: a possible Mechanism of protection. Pharmacol Res., 41, 283-9. |
[29] | P Ragavendran, D Sophia, C Arulraj and V K Gopalakrishnan., 2012, Cardioprotective effect of aqueous, ethanol and aqueous ethanol extract of Aerva lanata (Linn.) against doxorubicin induced cardiomyopathy in rats. Asian Pac J Trop Biomed., 1-7. |
[30] | T Vijay, M S D Rajan, K Sarumathy, S Palani and K Sakthivel., 2011, Cardioprotective, antioxidant activities and phytochemical analysis by GC-MS of Gmelina arborea (GA) in doxorubicin-induced myocardial necrosis in Albino rats. J Appl Pharm Sci. 01 (05), 198-204. |
[31] | MB Popp, AK Kirkemo, S D Morrison and MF Brennan., 1984, Tumor and host carcass changes during total parenteral nutrition in an anorectic rat-tumor system. Ann Surg., 199, 205-210. |
[32] | BC Koti, A H M Vishwanathswamy, J Wagawade and A H M Thippeswamy., 2009, Cardioprotective effect of lipistat against doxorubicin induced myocardial toxicity in albino rats. Indian J of Exp Biol., 47, 41-46. |
[33] | M Asanoma, K Takahashi, M Miyabe, K Yamamoto, N Yoshimi, H Mori and Y Kawazoe., 1994, Inhibitory effect of topical application of polymerized ferulic acid, a synthetic lignin, on tumor promotion in mouse skin two stage tumorigenesis. Carcinogenesis., 15, 2069-71. |
[34] | Lesca P., 1983, Protective effects of ellagic acid and other plant phenols on benzo[a] pyrene-induced neoplasia in mice. Carcinogenesis., 4, 1651-1653 |